Economic impact of patients admitted to stroke units in Spain
M. Yébenes(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), Núria González-Rojas(Boehringer Ingelheim (Spain)), Manuel Quintana, Javier Mar(Hospital Alto Deba), Virginia Becerra(Boehringer Ingelheim (Spain)), José Álvarez‐Sabín, Jaime Masjuán(Universidad de Alcalá), Covadonga Torres(Pharmacoeconomics and Health Outcomes Research Iberia (Spain))
Cited by 98
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke
|Stroke|2006|436
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385